Fighting Infectious Disease
Our commitment to combatting infectious disease is significant. In 2023, we provided access to high-quality and affordable ARVs to nearly 125 countries. This includes providing ARV treatment to approximately 8.6 million patients, more than 670,000 of whom are children living with HIV/AIDS. In the U.S., we have launched lower-cost options to several common treatments in an effort to reduce the high cost of care. And recently, we partnered with the TB Alliance to develop a treatment for multi-drug-resistant tuberculosis.
Delivering on Access to Primary Care in Africa
We are proud to have contributed financially to the establishment of two “Mpathy” primary care clinics to serve the people of Diepsloot, a growing township in South Africa.
Dispensary of Hope
Since 2012, Viatris has partnered with Dispensary of Hope, an organization that connects medication surplus from manufacturers and physicians with low-income and underinsured patients in the U.S. We have donated more than 338 million doses spanning 13 drug classes.